Yahoo Web Search

Search results

    • 3 No-Brainer Stocks to Buy in May

      3 No-Brainer Stocks to Buy in May

      Motley Fool via Yahoo Finance· 4 hours ago

      The big biotech already has an approved product in two of those markets. Gene-editing therapy Casgevy is a one-and-done functional cure for sickle cell...

    • Novo Nordisk: Growth Is Still A Better Choice

      Novo Nordisk: Growth Is Still A Better Choice

      GuruFocus.com via Yahoo Finance· 6 days ago

      So, its most promising developments are amycretin, etavopivat and CagriSema, which demonstrate competitive advantages relative to "gold standards" in the...

    • TIME100 Health: Stuart Orkin

      TIME100 Health: Stuart Orkin

      Time via Yahoo News· 3 days ago

      “But no one had any clue what that really meant; it was kind of a Disney fantasy.” Orkin focused his attention on the hemoglobin gene, which is mutated...